RSS Feeds
Search

Press releases

Press releases

Displaying 1..2 of 2 - per page
Order by
Leaders in oncology drug discovery, development and investment converge on Cambridge - 12 May 2011
Life Science Leadership Series – Oncology
12 May 2011
Clare College, Cambridge
To complement the global biopartnering conferences, share knowledge and engage thought leaders in challenging each other to progress the development of new treat More
TAPESTRY INITIATES DOSING OF PHASE I CLINICAL TRIAL FOR TPI 287
Novel Third Generation Taxane Designed to Overcome Multidrug and Mutant Tubulin Resistance More
Displaying 1..2 of 2 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
US Oncology, Inc. - SWOT Analysis
Nov 2010 - 26 pages - $125
US Oncology, Inc.: SWOT Analysis & Company Profile
Dec 2010 - 19 pages - $99
Molecular Targeted Cancer Therapies Market Forecast
Aug 2009 - $15,200
Cancer Targeted Therapies and Immunotherapies Market Forecast
Aug 2010 - $15,200
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
US Oncology, Inc. - Strategy and SWOT Report
Jun 2011 - 34 pages - $125
Top 20 Cancer Therapy Brands in Australia Forecast
Mar 2010 - $5,700
Avastin and the AVADO Trial Survey
Feb 2008 - $2,500
Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
Mar 2011 - 120 pages - $3,500
ZIOPHARM Oncology Inc: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile
Jun 2008 - 40 pages - $495
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us